| 112.12 0.63 (0.57%) | 04-18 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 137.87 | 1-year : | 161.03 |
| Resists | First : | 118.04 | Second : | 137.87 |
| Pivot price | 111.94 |
|||
| Supports | First : | 107.51 | Second : | 101.01 |
| MAs | MA(5) : | 111.21 |
MA(20) : | 112.02 |
| MA(100) : | 108.19 |
MA(250) : | 104.25 |
|
| MACD | MACD : | 0.2 |
Signal : | 0.3 |
| %K %D | K(14,3) : | 41.8 |
D(3) : | 38.4 |
| RSI | RSI(14): 51.5 |
|||
| 52-week | High : | 140.23 | Low : | 70.23 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ IRTC ] has closed below upper band by 48.4%. Bollinger Bands are 37.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 114.64 - 115.1 | 115.1 - 115.58 |
| Low: | 108.75 - 109.21 | 109.21 - 109.7 |
| Close: | 111.34 - 112.17 | 112.17 - 113.01 |
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
Sun, 14 Apr 2024
WCM Investment Management LLC Has $14.50 Million Stake in iRhythm Technologies, Inc. (NASDAQ:IRTC) - MarketBeat
Mon, 08 Apr 2024
Shareholders that lost money on iRhythm Technologies, Inc.(IRTC) Urged to Join Class Action - Contact Levi ... - PR Newswire
Fri, 05 Apr 2024
Investors who lost money on iRhythm Technologies, Inc.(IRTC) should contact The Gross Law Firm about pending ... - PR Newswire
Fri, 05 Apr 2024
Loss-Making iRhythm Technologies, Inc. (NASDAQ:IRTC) Expected To Breakeven In The Medium-Term - Yahoo Finance
Wed, 03 Apr 2024
IRTC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that iRhythm Technologies, Inc. Investors ... - GlobeNewswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 31 (M) |
| Shares Float | 31 (M) |
| Held by Insiders | 1 (%) |
| Held by Institutions | 109 (%) |
| Shares Short | 2,550 (K) |
| Shares Short P.Month | 1,800 (K) |
| EPS | -4.04 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 6.78 |
| Profit Margin | -25.1 % |
| Operating Margin | -19.9 % |
| Return on Assets (ttm) | -14 % |
| Return on Equity (ttm) | -54.9 % |
| Qtrly Rev. Growth | 17.7 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 15.83 |
| EBITDA (p.s.) | -3.03 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -50 (M) |
| Levered Free Cash Flow | -10 (M) |
| PE Ratio | -27.76 |
| PEG Ratio | 0 |
| Price to Book value | 16.51 |
| Price to Sales | 7.08 |
| Price to Cash Flow | -69.65 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|